These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Overview of Histone Modification. Zhang Y; Sun Z; Jia J; Du T; Zhang N; Tang Y; Fang Y; Fang D Adv Exp Med Biol; 2021; 1283():1-16. PubMed ID: 33155134 [TBL] [Abstract][Full Text] [Related]
27. Histone acetylation and chromatin signature in stem cell identity and cancer. Shukla V; Vaissière T; Herceg Z Mutat Res; 2008 Jan; 637(1-2):1-15. PubMed ID: 17850830 [TBL] [Abstract][Full Text] [Related]
28. Translational epigenetics: clinical approaches to epigenome therapeutics for cancer. Selcuklu SD; Spillane C Epigenetics; 2008; 3(2):107-12. PubMed ID: 18437050 [TBL] [Abstract][Full Text] [Related]
29. IDIBELL cancer conference on metastasis and angiogenesis. Carmona FJ; Esteller M Cancer Res; 2011 Oct; 71(19):6097-101. PubMed ID: 21933886 [TBL] [Abstract][Full Text] [Related]
30. [What is epigenetics? Strategies for research and application to cancer]. Van Seuningen I Ann Pathol; 2009 Nov; 29 Spec No 1():S28-30. PubMed ID: 19887245 [No Abstract] [Full Text] [Related]
32. Review-Epigenetic therapy for cancer. Saleem M; Abbas K; Manan M; Ijaz H; Ahmed B; Ali M; Hanif M; Farooqi AA; Qadir MI Pak J Pharm Sci; 2015 May; 28(3):1023-32. PubMed ID: 26004710 [TBL] [Abstract][Full Text] [Related]
33. Metabolic interactions with cancer epigenetics. Gao X; Reid MA; Kong M; Locasale JW Mol Aspects Med; 2017 Apr; 54():50-57. PubMed ID: 27620316 [TBL] [Abstract][Full Text] [Related]
34. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine. Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380 [TBL] [Abstract][Full Text] [Related]
35. Unveiling epigenetic regulation in cancer, aging, and rejuvenation with in vivo reprogramming technology. Sogabe Y; Seno H; Yamamoto T; Yamada Y Cancer Sci; 2018 Sep; 109(9):2641-2650. PubMed ID: 29989289 [TBL] [Abstract][Full Text] [Related]
36. Investigation of epigenetics in kidney cell biology. Li LX; Agborbesong E; Zhang L; Li X Methods Cell Biol; 2019; 153():255-278. PubMed ID: 31395383 [TBL] [Abstract][Full Text] [Related]
37. Metabolic recoding of epigenetics in cancer. Wang YP; Lei QY Cancer Commun (Lond); 2018 May; 38(1):25. PubMed ID: 29784032 [TBL] [Abstract][Full Text] [Related]
38. [Research progress on the relationship between nutrition and cancer epigenetics---histone modification mechanisms]. Teng LJ; Li K Ai Zheng; 2007 Sep; 26(9):1034-8. PubMed ID: 17927868 [TBL] [Abstract][Full Text] [Related]
39. Epigenetic Targets and their Inhibitors in Cancer Therapy. Zhao L; Duan YT; Lu P; Zhang ZJ; Zheng XK; Wang JL; Feng WS Curr Top Med Chem; 2018; 18(28):2395-2419. PubMed ID: 30582481 [TBL] [Abstract][Full Text] [Related]
40. Rebelled epigenome: histone H3S10 phosphorylation and H3S10 kinases in cancer biology and therapy. Komar D; Juszczynski P Clin Epigenetics; 2020 Oct; 12(1):147. PubMed ID: 33054831 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]